Press releases and general news items involving Plakous Therapeutics Inc.

May 15

New Board Member

Plakous Therapeutics, Inc. is excited to announce the addition of James Kalinovich to its Board of Directors. James brings strong financial expertise with 30 years in corporat…

Read More
Jul 5

NCBiotech Funding

Plakous Therapeutics, Inc. today announced it is has received more than $300,000 in funding from the North Carolina Biotechnology Center (NCBiotech)…

Read More
Aug 25

Mayo Clinic Agreement

Plakous Therapeutics, Inc. announced that it has signed a know-how license agreement with Mayo Clinic. The multi-year agreement will focus on understanding the results of a na…

Read More
Jul 7

NIH Funding Award

Plakous Therapeutics, Inc. received a notice of award for a Phase I-II Fast-Track Small Business Innovation Research (SBIR) grant providing up to $1,725,000 from the Eunice…

Read More
Jun 18

FDA Designations

Plakous Therapeutics, Inc. has been granted orphan drug and rare pediatric disease designations for its human placental extract, Protego-PDTM for the prevention of necrotizing…

Read More